Publication Name	World Journal of Gastroenterology
Manuscript ID	5030
Country	China

Received	2013-08-09 08:26
Peer-Review Started	2013-08-10 11:55
To Make the First Decision	2013-09-09 16:48
Return for Revision	2013-09-10 14:20
Revised	2013-09-20 22:37
Second Decision	2013-10-17 14:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-10-18 08:05
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-12-12 09:43
Typeset the Manuscript	2013-12-29 20:13
Publish the Manuscript Online	2014-01-19 14:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Juan Du, Yan-Yan Ma, Chao-Hui Yu and You-Ming Li
Funding Agency and Grant Number	Funding Agency Grant Number Zhejiang Provincial Natural Science Foundation of China LQ13H030002 Medical and Health Science Fund of Health Bureau of Zhejiang Province, China 2013KYB089
Corresponding Author	You-Ming Li, MD, Department of Gastroenterology, The First Affiliated Hospital, Medical School, Zhejiang University, Hangzhou 310003, Zhejiang Province, China. zlym@zju.edu.cn
Key Words	Pentoxifylline; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Meta-analysis
Core Tip	Recently, more researchers have been attempting to identify new treatments for nonalcoholic fatty liver disease (NAFLD), however, no firm conclusions have been reached. Thus, it is necessary to conduct a meta-analysis to assess the efficacy of pentoxifylline. Our analysis showed that pentoxifylline therapy significantly decreased body weight, alanine aminotransferase, aspartate transaminase, glucose and tumor necrosis factor-α. Pentoxifylline also reduced the NAFLD activity score and improved lobular inflammation in NAFLD patients.
Publish Date	2014-01-19 14:17
Citation	Du J, Ma YY, Yu CH, Li YM. Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2014; 20(2): 569-577
URL	http://www.wjgnet.com/1007-9327/full/v20/i2/569.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i2.569

Full Article (PDF)	WJG-20-569.pdf
Full Article (Word)	WJG-20-569.doc
Manuscript File	5030-Review.doc
Answering Reviewers	5030-Answering reviewers.pdf
Copyright License Agreement	5030-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5030-Language certificate.PDF
Peer-review Report	5030-Peer reviews.pdf
Scientific Editor Work List	5030-Scientific editor work list.doc